Davenas, Benveniste et al. 1988;
Human basophil degranulation triggered by very dilute antiserum against IgE.
Nature Vol.333, Juni 1988.
 

Homøopatisk medicin - energimedicin?
D. Knapp. 1985;
Die bioenergetische Strahlung und homøopatische Medikamente.
CHK, 2, 1985 s. 74-82.

L. Hadji, B. Arnoax, J. Benveniste.  1991;
Effect of dilute histamine on coronary flow of guinea-pig isolated heart. Inhibition by a magnetic field.
Abstract from FASEB 1991.
 

Potensvariationer
R. I. Jones, M.D. Jenkins. 1988;
Plant responses to homoeopathic remedies.
British Homoeopathic Journal 1988; 70:120-8.

G. Harish, M. Kretschmer.
Jenseits vom Milligram.
Springer Verlag, s. 21-41.

G. Harish, M. Kretschmer.
Jenseits vom Milligram.  Die Biochemie auf der Spuren der Homeôpathie.
Springer Verlag (ISBN 3-540-52424-X)
 

Biokemiske forsøg med homøopatisk medicin
E. Davenas, J. Benveniste et al. 1988;
Human basophil degranulation triggered by dilute antiserum against IgE.
Nature 1988, vol.333, s. 316-318.

B. Poitevin, E. Davenas, J. Benveniste. 1988;
In vitro degranulation of human basophils is modulated by lung histamine and Apis Mellifica.
British Jour. of Clinic. Pharmacol. 1988, 25, s. 439-444.

Benveniste, Davenas, Ducot et al. 1991;
Agitation of highly dilute solutions does not induce specific biological activity.
C. R. Acad. Scr. Paris t., 1991. 312, Serie II, p. 461-466.

C. Petit, B. Belson, R. Got. 1989;
Effect of homoeopathic dilutions on subcellular enzymatic activity.
Human Toxocol. 1989, 8, 125-129.

H. Wagner et al.
Die Beeinflussung der Phagozytosefähigkeit von Granulozyten durch homöopatische Arzneipräparate.
Arzneim.-Forch./Drug Res. 36(11), 9.

Pedersen P.A. 1972;
Eksperimentel påvisning af virkninger af potenserede substanser, 14. okt. 1972, nr. 42, Farmaceutisk Tidende, Dansk Farmaceutforening
 

Kliniske Undersøgelser 1977-1991
Savage R. H. et al. 1977;
A double blind trial to assess the benefit from Arnica montana in acute stroke illness.
The British Homeopathic Journal, Oct. 1977; 207-13.

Gibson et al. 1980;
Homeopathic therapy in rheumatoid arthritis: Evaluation by a double blind clinical therapeutic trial.
Br. j. Clin. Pharmacol. 1980, 9; 453-59.

Shipley M. et al. 1983;
Controlled trial of homeopathic treatment of osteoarthritis.
Lancet. Jan. 15, 1983; 97-98.

Reilly D. T. et al. 1986;
Is homeopathy a placebo response ?
Controlled trial of homeopathic potency. With pollen in hayfever as a model.
Lancet. Oct. 18. 1986; 881-885.

Mayaux M. J. et al. 1988;
Controlled trial in postoperative ileus.
Lancet, Mar. 5. 1988; 528-29.

Zell J. et al.  1988;
Treatment of acute sprains of the ankle. (summary)
Fortchr. Med 106 JG 1988. 96-100.

Fisher P. et al.  1989;
Effect of homeopathic treatment of fibrositis (primary fibromyalgia).
BMJ, Aug. 5. 1989; 365-366.

Ferly P. et al.  1989;
A controlled trial of a homeopathic preparation in the treatment of influenza-like syndrome.
Br. J. Clin. Pharmacol. 1989; 29, 329-35.

Brigo B. et al.  1991;
Homeopathic treatment of migraines: A randomized double-blind controlled study of sixty cases (Homeopathic remedy versus placebo).
The Berlin Journal on research in homoeopathy. March 1991; 2, 98-106.

Tveiten D., Bruseth S., Bochgrevink C., Løhne K. 1990;
Effekt av Arnica D 30 ved hård fysisk anstrengelse. Randomiseret dobbelt-blindforsøg under Oslo Maraton, 1990.
Tidsskr. Nor. Lægeforen. nr. 30, 1991;111: 3630-1.

Walach, H 1992;
Wissenschaftliche Homöopathische Arzneimittelprüfung. Doppelblinde crossover-Studie einer homöopatischen Hochpotenz gegen Placebo, Haug, Heidelberg.
 

Oversigtsartikler
Tveiten D. og Bruseth S.  1991;
Homeopati - fortid eller del av fremtidens medisin ?
Tidsskr. Nor. Lægeforen. nr. 30, 1991;111

Kleinen J., Knipschild P., Riet G.t. 1991;
Clinical trials of homoeopathy,
British Medical Journal, 1991 Feb. 9; 302(6772): 316 - 23.

Linde K. et al. 1997;
Are the clinical effects of homoeopathy placebo effects ? A meta-analysis of placebo-controlled trials. The Lancet vol. 350 september 20, 1997
 

Biologis forskning

oInfinitesimal-doser: Ultra lave dosers påvirkning af cellers biologiske aktivitet
Safrit J. T. Belldegrun A., Bonavida B. 1993;
Sensitivity of Human Renal Cell Carcinoma Lines to TNF, Adriamycin, and combination: Role of TNF mRNA induction in Overcoming Resistance.
The Journal of Urology, 1993, 149: 1202-1208.

Mizutani Y., Bonavida B. 1993;
Overcoming Cis-Diamminedichloroplatinum (II) Resistance of Human Ovarian Tumor Cells by combination Treatment with Cis-Diamminedichloroplatinum (II) and Tumor Necrosis Factor-Alpha,
Cancer. 1993, 72: 809-818.

Mizutani Y., Bonavida B. 1993;
Overcoming TNF-_ox and CDDP Resistance of a Human Ovarian Cancer Cell Line (C30) by Treatment with Buthionine Sulfoximine in combination with TNF-_ox and/or CDDP.
International Journal of Oncology, 1993, 3: 229-235.

Safrit J. T., Bonavida B. 1992;
Sensitivity Resistant human Tumor Cell Lines to Tumor Necrosis Factor and Adriamycin Used in Combination: Correlation between Down-Regulation of Tumor Necrosis Factor-Messenger RNA Induction and Overcoming Resistance.
Cancer Research, 1992, 52: 6630-6637.

Safrit J. T. Tsuchitani T., Berek J., Zighelboim J., Bonavida B.: 1991;
Overcoming Drug Resistance by the Synergistic Activity of Drug and Tumor Necrosis Factor, in: New Frontiers in the Therapy of Malignancies: from Biological Approaches to Clinical Trials, Ed.
G. Mantovani et al. 1991.

Tsuchitani T., Zighelboim J., Berek J., Bonavida B.: 1991;
Potentiation of Cytotoxicity against Human Ovarian Cell-Lines with Combinations of Subtoxic Concentrations of Tumor Necrosis Factor and Adriamycin or Cisplatinum.
Journal Cell. Pharmacol., 1991, 2: 1-11.

Morimoto H., Yonehara S., Bonavida B.: 1993;
Overcoming Tumor Necrosis Factor and Drug Resistance of Human Tumor Cell Lines by Combination Treatment with Antifas Antibody and Drugs or Toxins.
Cancer Research, 1993, 53: 2591-2596.

Bonavida B.: 1992;
TNF and TNF Receptors: Structure, Mechanism of Action and Role in Disease and Therapy.
Drugs of Today, 1992, Vol. 28, No. 7: 521-525.

Gan X. H., Jewett A., Bonavida B.: 1991;
Activation of Human Peripheral-Blood-Derived Monocytes by cis-Diamminedichloroplatinum: Enhanced Tumoricidal Activity and Secretion of Tumor Necrosis Factor-Alpha.
Nat. Immun. Cell. Growth Regul., 1991, 251.

Bonavida B., Safrit J. T., Morimoto H.: 1993;
Reversal of Drug Resistance: Synergistic Anti-Tumor Cytotoxic Activity by Combination Treatment with Drug and TNF or Toxins.
Cancer Therapy, 1993, 75: 169-176.

Safrit J. T., Berek J. S., Bonavida B.: 1992;
Sensitivity of Drug-Resistant Human Ovarian Tumor Cell Lines to Combined Effects of Tumor Necrosis Factor (TNF-_ox) and Doxorubicin: Failure of the Combination to Modulate the MDR Phenotype.
Gynecologic Oncology, 1992, 48: 214-220.

Morimoto H., Safrit J. T., Bonavida B.: 1991;
Synergistic Effect of Tumor Necrosis and Diphtheria Toxin-Mediated Cytotoxicity in Sensitive and Resistant Human Ovarian Tumor Cell Lines.
The Journal of Immunology, 1991, Vol. 147, No. 8: 2609-2616.

Morimoto H., Bonavida B.: 1992;
Diphtheria Toxin- and Pseudomonas A Toxin- Mediated Apoptosis: ADP Ribosylation of Elongation Factor-2 is Required for NDA Fragmentation and Cell Lysis and Synergy with Tumor Necrosis Factor-_ox.
The Journal of Immunology, 1992, 49: 2089-2094.

Safrit J. T., Bonavida B.: 1992;
Hierarchy of In Vitro Sensitivity and Resistance of Tumor Cells to Cytotoxic Effector Cells, Cytokines, Drugs and Toxins.
Cancer Immunology Immunotherapy, 1992.

Niebauer G. W., Dorci M. et al. 1980;
Die Wirkung von homöopatischem Arnica D12 und Actihaemyl auf die Wundheilung im Tierexperiment.
Der praktische Tierartzt 2/ 1980 s. 128-132.

Oberbaum et al (Israel). 1992;
Wound healing by homeopathic Silica-dilution in mice.
Harefuah 1992 Ang; 123 (3-4); 79-82, 156.

Santini R. Et al. 1991;
Effects of a low-Doses Treatment With Cuprum on Neostigmine Digestive Action in Female Mice.
Drug Development Research 24:231-233

Fisher P. Et al. 1987;
The influence of the Homoeopathic Remedy Plumbum Metallicum on the Excretion Kinetics of Lead in Rats.
Human Toxicol. 6. 321-324

Cazin J. C. 1987;
A study of the effect of Decimal and Centesimal Dilusions of Arsenic on the Retension and Mobilization of Arsenic in the Rat.
Human Toxicol. 6. 315-320

Davenas E. Et al. 1987;
Effect on mouse peritoneal macrophages of orally administered very high dilutions of Silicea.
European Journal of Pharmacology, 135 (1987) 313-319

Girolami J. P. 1988;
Renal Lallikrein excretion as a distal nephrotoxicity marker during Cadmium exposure in rats.
Toxicology, 55 (1989) 117-129
 

Aspirins effekt i infinitesimale doser
Lalanne M. C., De Seze O., Doutremepuich C., Belon P.: 1991;
Could Proteolytic Enzyme Modulate the Interaction Platelets/Vessel Wall in the Presence of ASA at Ultra Low Doses ?
Thrombosis Research, 1991, 63: 419-426.

Lalanne M. C., Doutremepuich C., De Seze O., Belon P.: 1990;
What is the Effect of Acetylsalicylic Acid at Ultra Low Dose on the Interaction Platelets/Vessel Wall ?
Thrombosis Research, 1990, 60: 231-236.

Doutremepuich C., De Seze O., Le Roy d., Lalanne M. C., Anne M. C.: 1990;
Aspirin at Very Ultra Low Dosage in Healthy Volunteers: Effects on Bleeding Time, Platelet Aggregation and Coagulation.
Haemostasis, 1990, 20: 99-105.

Doutremepuich C. Aguejouf O., Pintigny D., Sertillanges M. N., De Seze O.:
Thrombogenic Properties of Ultra Low Dose of Acetylsalicylic Acid in a Vessel Model of Laser Induced Thrombus Formation, in press.

Doutremepuich C., Paillet d., De Seze O., Anne M. C., Paccalin J., Quilichini R.: 1988;
Variation du temps de saignement après administration à différentes posologies d'acide acetyl salicylique chez le volontaire sain (= Bleeding Time after Administration of Acetyl Salicylic Acid in Healthy Volunteers).
Annales Pharmaceutiques Francaises, 1988, 46, No. 1: 35-39.

Vesvres M. H., Doutremepuich F., Lalanne M. C. L., Doutremepuich C. H. 1993;
Effects of Aspirin on Embolization in an Arterial Model of Laser-Induced Thrombus Formation.
Haemostasis, 1993, 23: 8-12.

Doutremepuich C., Paillet D., Anne M. C., De Seze O., Paccalin J., Quilichini R.: 1987;
Template Bleeding Time after Ingestion of Ultra Low Dosages of Acetyle Salicylic Acid in Healthy Subjects: Preliminary Study.
Thrombosis Research, 1987, 48: 501-504.

Lalanne M. C., Ramboer I., De Seze O., Doutremepuich C.: 1992;
In Vitro platelets/Endothelial Cells Interaction is Presence of Acetylsalicylic Acid at Various Dosages.
Thrombosis Research, 1992, 65: 33-43.

Doutremepuich C., De Seze O., Anne M. C., Hariveau E., Quilichini R.: 1987;
Platelet Aggregation on Whole Blood after Administration of Ultra Low Dosage Acetylsalicylic Acid in Healthy Volunteers.
Thrombosis Research, 1987, 47: 373-377.
 

Højpotensers farmakologi:
Sainte-Laudy J., Cherruault Y., Papapanaotou C.:  1987;
Analyse mathématique et modélisation du test de dégranulation (TDBH) (= Mathematical Analysis and Modelling og the Basophil Degranulation Test (HBDT).
Bio-Sciences, 1987, Vol. 5, No. 6: 210-214.

Sainte-Laudy J.: 1987;
Standardization of Basophil Degranulation for Pharmaceutical Studies.
Journal of Immunological Methods, 1987, 98: 279-282.

Sainte-Laudy J., Belon P.: 1993;
Inhibition of Human Basophil Activation by High Dilution of Histamine.
Agents Actions, 1993, 38: C245-C247.

Sainte-Laudy J., Sambucy J. L., Belon P.: 1991;
Biological Activity of Ultra Low Doses I/Effect of Ultra Low Doses of Histamine on Human Basophil Degranulation Triggered by D. Pteronyssinus Extract, in:
Ultra Low Doses, 1991, Taylor & Francis: 127-138.

Shelley W., Juhlin L.: 1961;
A New Test for Detecting Anaphylactic Sensitivity: The Basophil Reaction.
Nature, 1961, 191: 1056-1060.

Hadjaj B., Cherruault Y., Sainte-Laudy J.: 1993;
Control of Basophil Degranulation.
Int. i. Biomed. Comput., 1993, 32: 151-159.

Cherruault Y., Guillez A., Sainte-Laudy J., Belon P.: 1989;
Etude mathématique et statistique des effects de dilutions successives de chlorhydrate d'histamine sur la réactivité des basophiles humains (= Statistical and Mathematical Study of the Effect of Successive Dilutions of Histamine Hydrochloride on the Reactivity of Human Basophils).
Bio-Sciences, 1989, 7: 63-72.

Sainte-Laudy J., Belon P.: 1991;
Biological Activity of Ultra Low Doses II/Effect of Ultra Low Doses of Histamine on Human Basophil Degranulation Triggered by Anti-IGE, in:
Ultra Low Doses, 1991, Taylor & Francis: 139-143.

Papanaotou C., Guellal S., Cherruault Y., Belon P., Sainte-Laudy J.: 1987;
Mathematical Analysis and Modelling in Homeopathy, Proceedings of the Seventh international Congress of Cybernetics and Systems,
London, 7-11, September 1987.

Belon P.: 1987;
Modelization of the Effect of Hahnemannian Dilutions on Human Basophil Degranulation, proceedings of the Seventh International Congress of Cybernetic and Systems,
London 7-11, September 1987.
 

Homøopati - Immun-allergologi og inflammation.
Poitevin B., Aubin M., Benveniste J.: 1986;
Approche d'une analyse quantitative de l'effet d'Apis mellifica sur la dégranulation des basophiles humains in vitro (= Approach to a Quantitative Analysis of the Effect og Apis Mellifica on in Vitro Human Basophil Degranulation.
Innov. Tech. Biol. Med., 1986, Vol. 7, No. 1: 64-68.

Poitevin B., Davenas E., Benveniste J.: 1988;
In Vitro Immunological Degranulation of Human Basophils is Modulated by Lung Histamine and Apis Mellifica.
Br. I. Clin. Pharmac., 1988, 25: 439-444.

Benveniste J., Davenas E., Ducot B., Cornillet B., Poitevin B., Spira A.: 1991;
L'agitation de solutions hautement diluées n'induit pas d'activite biologique spécifique (= Agitation of Highly Dilute Solutions Does Not Induce Specific Biological Activity).
C. R. Acad. Scie. Paris, 1991, t. 312, Série II: 461-466.

Davenas E., Beauvais J., Amara J. et al: 1988;
human Basophil Degranulation Triggered by Very Dilute Antiserum Against IgE.
Nature, 1988, No. 6176, 333: 616-618.

Ovelgonne J. H., Bol A. W. J. M., Hop W. C. J., Van Wijck R.: 1992;
Mechanical Agitation of Very Dilute Antiserum Has No Effect on Basophil Staining Properties.
Experientia, 1992, 48: 504-508.
 

Fysisk-kemiske mekanismer

Infinitesimal dosers virkningsmekanisme

Demangeat J. L., Demangeat C., Gries P., Poitevin B., Contantinesco A.: 1992;
Modifications des temps de relaxation RMN à 4 Mhz des protons du solvant dans les très hautes dilutions salines de silice/lactose (= Modifications of 4 Mhz NMR proton Realization Time sin Very High Dilutions of Silica/Lactose in Saline).
I. Me. Nucl. Biophy., 1992, 16, 2: 135-145.

Cazin J. C., Cazin M., Chaoui A., Belon P.: 1991;
Influence of Several Physical Factors on the Activity of Ultra-Low Doses, in:
Ultra Low Doses, 1991, Taylor & Francis: 69-80.

Poitevin B.: 1993;
Mécanismes d'action des médicaments à usage homéopathique. Données récentes et hypothèses; 1 - Mécanismes physicochimiques. (= Mechanisms of Action of Medicines for Homeopathic Use. Recent Data and Hypotheses; 1 - Physical-Chemical Mechanisms).
Homéopathie Eur., 1993, 1: 41-50.

Suslik S. K.: 1988;
Correspondence.
Nature, 1988, 334: 375-376.
 

Klinisk prøvning

Klinisk prøvning og demonstration af homøopatiens effekt.
Jacobs J., Jimenz M., Gloyd S.S., Gale J. L., Crothers D.: 1994;
Treatment of Acute Childhood Diarrhea with Homeopathic Medicine: A Randomized Clinical Trial in Nicaragua.
Pediatrics, 1994, 93: 719-725.

Kleijnen J., Knipschild P., Riet G.: 1991;
Clinical Trials of Homeopathy.
British Medical Journal, 1991, 302: 316-323.

Ferley J. P. Zmirou D., D'Adhemar D., Balducci F.: 1989;
A Controlled Evaluation of a Homoeopathic Preparation in the Treatment of Influenza-like Syndromes.
British Journal of clinical Pharmacology, 1989, 27: 329-335.

Reilly D. T., Taylor M. A., MC Sharry C., Aitchison T.: 1986;
Is Homeopathy a Placebo Response ? Controlled Trial of Homeopathic Potency, with Pollen in Hayfever as Model.
The Lancet, 1986, 881-886.

De Lange De Klerk E. S. M., Blommers J., Kuik D. J., Bezemer P. D., Feenstra L.: 1994;
Effect of Homeopathic Medicines on Daily Burden of Symptoms in Children with Recurrent Upper Respiratory Tract Infections.
British Medical Journal, 1994, 309: 1329-1332.

Benzecri J. P., Maiti G. D., Belon P., Questel R.: 1991;
Comparaison ente quatre methodes de sevrage après une thérapeutique anxiolytique (= Comparison between Four Methods of Weaning after Treatment by Minor Tranquillizers).
Les Cahiers de l'Analyse des Données, 1991, Vol. XVI, No. 4: 389-402.

Lasveaux L.: 1989;
Traitements homéopath-iques du choléra dans la France du XIXème siècle (= Homeopathic Treatments for Cholera in 19th Century France), Collection due Caducée.
Boiron Ed. Lyon, 1989.

Fisher P.: 1986;
An Experimental Double-blind Clinical Trial Method in Homeopathy. Use of a Limited Range of Remedies to Treat Fibrosis.
British Homoeopathic Journal, 1986, 75: 142-147.

Gibson R. G., Gibson S.L.M., Mac Neill A. D., Buchanan W.W.: 1980;
The Place for Non-Pharmaceutical Therapy in Chronic Rheumatoid Arthritis: A Critical Study of Homeopathy.
British Homoeopathic Journal, 1980, 69: 121-133.

Cruchet: 1854;
L'Homéopathie et le choléra de 1854, résponses aux homéopathes en général et à M. Chargé en particulier (= in Homeopathy and Cholera in 1854, Responses to Homeopaths in General and to M. Chargé in Particular).
Marseille, 1854.

Mabit J.: 1835;
Observations sur l'homéopathie (= Notes on homeopathy).
Paris Baillière, 1835.

Reilly D., Taylor M. A., Beattie N. G. M., Campbell J. H., MC Sharry C., Aitchison T. C., Carter R., Stevenson R. D.:  1994;
Is Evidence for Homeopathy Reproducible ?
The Lancet, 1994, 344: 1601-1606.

Fisher P., Greenwood A., Huskisson E. C., Turner P., Belon P.: 1991;
Traitement homéopathique de la fibromyalgie primaire: à propos de deux essais cliniques en double insu (= Homeopathic Treatment of Primary Fibromyalgia: Two Double-Blind Clinical Trials).
Homéopathie Francaise, 1991, 79, 4: 15-22.

Brigo B.: 1987;
Le traitement homéopathique de la migraine: une etude de 60 cas controlée en double aveugle (= Homeopathic Treatment of the Migraine: A study of 60 Cases, Controlled in Double-Blind).
Journal of Ligua Homeopathic International, 1987, 38: 18-25.

Ower R. M. N, Ives G.: 1982;
The Mustard Gas Experiments of the British Homoeopathic Society 1942.
Proceedings of the XXXV International homeopathic Congress, 1982, 258-269.

Gibson R. G., Gibson S. L. M., Mac Neill A. D., Gray G. H., Dick W. C., Buchanan W. W.: 1978;
Salicyclates and Homeopathy in Rheumatoid Arthritis: Preliminary Observations.
British Journal of Clinical Pharmacology, 1978, 6: 391-395.

Charge: 1855;
L'Homéopathie et ses detracteurs à l'occasion de l'épidémie de choléra qui a régné à Marseille en 1854 (= Homeopathy and its Detractors, Concerning the Cholera Epidemic of Marseille in 1854).
Paris Baillière, 1855.

Mabit J.: 1832;
Rapport sur le choléra morbus asiatique qui a eté observé à Bordeaux depuis le 4 août 1832 jusqu'à ce jour et sur la nécessité du complet assainissement de la ville (= Report on Asian Cholera Morbus which Was Observed in Bordeaux from Aug 4, 1832 Until Today, and on the Necessity of Draining og the City).
Bordeaux, Imprimerie Peletingeas, 1832.

Zicari D., Ricciotti F., Vingolo E. M., Zicari N.: 1992;
Valutazione dell'azione angioprotettiva di preparati de arnica nel trattamento della retinopatia diabetica (= Evaluation of the Angio-Protective Effect of Preparations of Arnica in the Treatment of Diabetic Retinopathy).
Bolentino de Oculistica, 1992, 5: 841-848.

Fisher P., Greenwood A., Huskisson E. C., Turner P., Belon P.: 1989;
Effect of homeopathic Treatment on Fibrosis (Primary Fibromyalgia).
British Medical Journal 1989, 299: 365-366.

Turner P.: 1987;
Editorial.
Human Toxicology, 1987, 6: 267-268.

Gibson R. G., Gibson S. L. M., Mac Neill A. D., Buchanan W.W.: 1980;
Homeopathic Therapy in Rheumatoid Arthritis: Evaluation by Double-Blind Clinical Therapeutic Trail.
British Journal of Clinical Pharmacology, 1980, 9: 453-459.

Paterson J.: 1944;
Report on Mustard Gas Experiments (Glasgow and London).
Journal of the American Institute of Homeopathy, 1944, 37: 47-50, 88-92.

Chevallier L. et al:
Le choléra, la première épidémie du XIXème siècle (= Cholera, The Foremost Epidemic of the 19th Century).
Societé d'Histoire de la Révolution de 1848. La Roche sur Yon: Imprimerie Centrale de l'Quest, t 20.
 

Anden vigtig forskning
Eisenberg D. M., Kessler R. C., Foster C., Norlock F. E., Calkins D. R & Delbanco T. L.: 1993;
Unconventional Medicine in the United States: Prevalence, Costs and Patterns of Use.
The New England Journal of Medicine, 1993, 328: 246-252.

Berkowitz C. D.: 1994;
Homoeopathy: Keeping an open mind.
The Lancet, 1994, 344, 701-702.